Publisher
Springer International Publishing
Reference13 articles.
1. Monserrat L, Ortiz-Genga M, Lesende I, Garcia-Giustiniani D, Barriales-Villa R, de Una-Iglesias D, et al. Genetics of cardiomyopathies: novel perspectives with next generation sequencing. Curr Pharm Des. 2015;21(4):418–30.
2. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA). Europace. 2011;13(8):1077–109.
3. Cuenca S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, Salas C, Gomez-Diaz I, et al. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. J Heart Lung Transplant. 2016;35(5):625–35.
4. Poptsova MS, Il'icheva IA, Nechipurenko DY, Panchenko LA, Khodikov MV, Oparina NY, et al. Non-random DNA fragmentation in next-generation sequencing. Sci Rep. 2014;4:4532.
5. Ion Semiconductor Sequencing. In Wikipedia, the free encyclopedia. 2017. Retrieved 02 July 2017, from
https://en.wikipedia.org/w/index.php?title=Ion_semiconductor_sequencing&oldid=780682285
.